151Indexed trials
mesh condition
Depressive Disorder, Major
Intelligence
Depressive Disorder, Major intelligence: 151 indexed trials, 31 recruiting studies, 110 sponsors across 50 countries.
31Recruiting
110Sponsors
50Countries
Leading sponsors
University of California, Los Angeles70 recruiting
Eli Lilly and Company50 recruiting
Massachusetts General Hospital41 recruiting
National Institute of Mental Health (NIMH)42 recruiting
St. Joseph's Healthcare Hamilton30 recruiting
AbbVie30 recruiting
Pfizer30 recruiting
University of Calgary30 recruiting
H. Lundbeck A/S30 recruiting
Shanghai Mental Health Center30 recruiting
Mclean Hospital20 recruiting
Naurex, Inc, an affiliate of Allergan plc20 recruiting
Geographic activity
United States77trials
Canada15trials
Germany10trials
France9trials
Spain9trials
Italy7trials
Japan6trials
South Korea6trials
Poland5trials
China5trials
Australia5trials
Russia5trials
Leading interventions
Transcranial Magnetic Stimulation7trials
Sertraline4trials
Escitalopram4trials
Ketamine Hydrochloride3trials
Ketamine3trials
Duloxetine Hydrochloride3trials
Vortioxetine3trials
Midazolam2trials
Rapastinel2trials
ECT2trials
DVS SR2trials
Cariprazine2trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.